If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
361.00    0.60 (0.17%)
Bid:
360.60
Ask:
361.20
Spread: 0.60 (0.166%)
Market Cap: £1.91b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Completes Refinancing Transactions

9 Oct 2024 07:00

RNS Number : 4219H
Hammerson PLC
09 October 2024
 

9 October 2024

Hammerson plc

("Hammerson" or the "Company/Group")

Hammerson completes refinancing transactions to underpin growth strategy

Following the successful issuance of its 12-year £400m bond, Hammerson sets out the final outcome of the new issuance and accompanying tender of the Company's outstanding bonds maturing in 2026 and 2028:

· 12-year £400m bond pricing confirmed on 3 October at a coupon of 5.875% representing a spread of 183 basis points over the reference gilt rate

· Strong demand led to peak order book in excess of £2.6bn (over 7x subscribed)

· The repurchase of a total of £411.6m bonds, comprising £168.4m of 6% 2026s and £243.2m of 7.25% 2028s

· An annualised net interest benefit to Hammerson of £3.6m1 per year (approximately £0.8m for the financial year ending 2024)

· This reduces weighted average gross interest from 3.8%2 to 3.6% and extends Hammerson's weighted average debt maturity from 2.9 years3 to 5.2 years

· The refinancing is largely leverage neutral; pro forma4 LTV at 30 June 2024 is 25.5% and net debt:EBITDA is 5.4x

 

Himanshu Raja, CFO of Hammerson plc, commented:

"The combined effect of our new £400m 5.875% bond maturing in 2036 and the tender of our existing short-dated sterling maturities reduces our ongoing interest costs and extends our weighted average debt maturity. The strong demand and competitive pricing are a clear recognition from investors of the strength of our portfolio, the robust balance sheet and the opportunity ahead of us."

 

1 Annualised interest benefit arises due to the weighted average interest cost on the bonds tendered (6% on 2026s and 7.87% on 2028s) being 7.1% and higher than the 5.875% coupon on the new issue, offset by the impact of new issue discounts and the reduction to interest receivable due to net cash outflows.

2 Weighted average gross interest rate at 30 June 2024 of 3.4% and pro forma for the refinancing of Dundrum in August 2024 of 3.8%.

3 Weighted average debt maturity at 30 June 2024 of 2.2 years and pro forma for the refinancing of Dundrum in August 2024 of 2.9 years. 

4 Pro forma for the tender and new issuance financing transactions and the disposal of the Group's interest in Value Retail generating net proceeds of £583m. Pro forma at 30 June 2024 reflecting only the disposal of the Group's interest in Value Retail; LTV was 24.7% and net debt:EBITDA was 5.3x.

 

ENDS

Hammerson plc

Investor Contact

Josh Warren, Hammerson, Director of Strategy, Commercial Finance and Investor Relations

 

 

 

+44 (0)20 7887 1053

MHP for Hammerson Media

Oliver Hughes

Ollie Hoare

 

+44 (0)7885 224 532

+44 (0)7817 458 804

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGKRNGDZM
Date   Source Headline
31st Aug 202311:15 amRNSBond Tender Offers
22nd Aug 20232:45 pmRNSHolding(s) in Company
21st Aug 20233:30 pmRNSHolding(s) in Company
18th Aug 20233:00 pmRNSHolding(s) in Company
14th Aug 20239:30 amRNSDividend Currency Conversion Announcement
10th Aug 20233:00 pmRNSHolding(s) in Company
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.